EA
RIGL icon

Emerald Acquisition’s Rigel Pharmaceuticals RIGL Stock Holding History

Emerald Acquisition’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$1.55M Buy
42,339
+16,843
+66% +$483K ﹤0.01% 1881
2016
Q2 		$568K Buy
+25,496
New +$634K ﹤0.01% 2415

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Emerald Acquisition's RIGL Position: Q3 2016 in Review

Emerald Acquisition increased its Rigel Pharmaceuticals (RIGL) stake by 66% in Q3 2016, buying an estimated $483K and bringing the position to 42,339 shares worth $1.55M. The position accounts for ﹤0.01% of the portfolio, ranked #1881.

Emerald Acquisition first reported a position in RIGL in Q2 2016 and has held it in 2 quarters since. 121 funds tracked by Wall St. Rank hold RIGL as of Q3 2016.

  • Emerald Acquisition held 42,339 shares of Rigel Pharmaceuticals worth $1.55M as of Q3 2016.
  • Emerald Acquisition bought 16,843 Rigel Pharmaceuticals shares in Q3 2016, an estimated $483K.
  • Rigel Pharmaceuticals made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #1881 holding.
  • Emerald Acquisition first reported a position in Rigel Pharmaceuticals in Q2 2016 and has held it in 2 quarters since.
  • 121 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.